Radiology vendor Aidoc raises $150M from Goldman Sachs and others
Aidoc has raised $150 million in fresh funding as the radiology artificial intelligence vendor seeks to expand into new clinical indications and capabilities.
Goldman Sachs led the Series E funding round with additional contributions from the General Catalyst venture capital firm, SoftBank Investment Advisers and NVentures, Nvidia’s VC arm. Aidoc has now raised over $500 million in total funding to date, including another $150 million last July.
Founded in 2016 and headquartered in New York, the company is a global leader in clinical AI. It holds the most U.S. Food and Drug Administration clearances for computer aided detection solutions on the market, powering care for 60 million patients annually.
“Aidoc pairs advanced technology with regulatory rigor in a way that few companies have achieved," Christian Resch, MBA, a partner at Goldman Sachs Growth and Aidoc board member since February, said in a statement April 29. “We believe this combination of innovation, safety, technical rigor and operational discipline positions Aidoc as a long-term leader in clinical AI,” he added later.
New funding will help support further development of Aidoc’s CARE Foundation Model. First introduced at RSNA 2024, the product can adapt to perform a wide variety of tasks with minimal training, different from other AI models focused on specific diseases. Aidoc said it also will use the money to build new capabilities such as automated imaging draft report creation to “power end-to-end clinical AI workflows.”
The company additionally plans to drive broader global deployment of its enterprise AI platform, with hospitals increasingly seeking to consolidate tools under a centralized operating framework. Aidoc’s technology has now been used to analyze over 110 million patient cases and is deployed at nearly 2,000 hospitals worldwide.
"By 2030, every complex diagnostic decision should be supported by AI that enables earlier detection and reduces preventable error," Elad Walach, co-founder and CEO of Aidoc, said in a statement. "This funding accelerates comprehensive disease coverage and advances end-to-end AI across CT and X-ray, spanning the full workflow including pixel to draft report within two years,” he added later.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.